Fundraising Fox

InCarda Therapeutics

Brisbane, US · Delaware corporation · 4 known investors

incardatherapeutics.com ↗

Incardatherapeutics develops drug therapies for treating atrial fibrillation using synergistic combinations of anti-arrhythmic agents, with delivery platforms designed for both hospital and at-home settings. The company targets reducing the clinical and economic burden of atrial fibrillation in the U.S. healthcare system.

BiotechDigital HealthMedical Devices

Founders & leadership

RN
Rangachari NarasimhanExecutive Officer, Director
MR
McCarthy ReenieDirector
GC
Grace ColonExecutive Officer, Director
BN
Bischofberger NorbertDirector
MS
Miller SamanthaExecutive Officer

Investors · 4

Asset Management CompanyMenlo Park · $500K – $2M
HealthCapStockholmvia Johan Christenson · board
Sofinnova VenturesMenlo Park · $100K – $15M
Deerfield Management CompanyreportedNew Yorkvia Andrew ElBardissi · board

Reported raises · per SEC filings

Form D private placements
▶$28MraisedOct 2020 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew ElBardissiDirector
  • Johan ChristensonDirector
  • Alan ColowickDirector
  • Isaac ChengDirector
  • Grace ColonExecutive Officer, Director
  • Dan WelchDirector
Offering amount
$50M
Amount sold
$28M
First sale
Oct 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$35.3MraisedNov 2019 · 24 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Grace ColonExecutive Officer, Director
  • Isaac ChengDirector
  • Bischofberger NorbertDirector
  • Alan ColowickDirector
  • Johan ChristensonDirector
  • Andrew ElBardissiDirector
  • Dan WelchDirector
Offering amount
$42.1M
Amount sold
$35.3M
Minimum investment
$1.8K
First sale
Oct 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.1MraisedMay 2017 · 16 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Rangachari NarasimhanExecutive Officer, Director
  • McCarthy ReenieDirector
  • Grace ColonExecutive Officer, Director
  • Bischofberger NorbertDirector
  • Miller SamanthaExecutive Officer
Offering amount
$2.5M
Amount sold
$2.1M
Minimum investment
$5K
First sale
Mar 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news